LEGEND BIOTECH CORP's ticker is LEGN and the CUSIP is 52490G102. A total of 156 filers reported holding LEGEND BIOTECH CORP in Q2 2022. The put-call ratio across all filers is 0.39 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $274,000 | -22.4% | 6,715 | +4.7% | 0.10% | -15.4% |
| Q2 2022 | $353,000 | -3.3% | 6,415 | -36.2% | 0.12% | +8.8% |
| Q1 2022 | $365,000 | -24.3% | 10,055 | -2.8% | 0.11% | -10.3% |
| Q4 2021 | $482,000 | -14.7% | 10,345 | -7.3% | 0.13% | -18.2% |
| Q3 2021 | $565,000 | +29.0% | 11,165 | +4.7% | 0.15% | +24.2% |
| Q2 2021 | $438,000 | +20.3% | 10,665 | -14.9% | 0.12% | +10.7% |
| Q1 2021 | $364,000 | +75.0% | 12,532 | +70.0% | 0.11% | +72.3% |
| Q4 2020 | $208,000 | -15.4% | 7,372 | -7.6% | 0.06% | -27.8% |
| Q3 2020 | $246,000 | -4.7% | 7,982 | +31.7% | 0.09% | -11.8% |
| Q2 2020 | $258,000 | – | 6,062 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JOHNSON & JOHNSON | 814,586 | $56,230,872 | 17.46% |
| Paradigm Biocapital Advisors LP | 1,805,717 | $124,648,645 | 9.63% |
| HHLR ADVISORS, LTD. | 6,436,533 | $444,313,873 | 9.46% |
| MATTHEWS INTERNATIONAL CAPITAL MANAGEMENT LLC | 1,123,692 | $77,568,459 | 9.09% |
| RA Capital Management | 6,264,707 | $432,452,724 | 8.16% |
| Tri Locum Partners LP | 116,768 | $8,060,495 | 3.00% |
| Nicholas Investment Partners, LP | 593,167 | $40,946,318 | 2.80% |
| E Fund Management (Hong Kong) Co., Ltd. | 51,679 | $3,567 | 2.66% |
| Avidity Partners Management LP | 798,900 | $55,148,067 | 1.93% |
| Boxer Capital, LLC | 600,000 | $41,418 | 1.92% |